PXN and infection: These results combined with the data regarding decreased infection at the higher levels of SHP-2 inhibitor, suggest that even though paxillin does not co-localize with the infection site, paxillin is moderately dephosphorylated during infection, and that SHP-2 may play a role, whether direct or indirect, in the dephosphorylation of paxillin.